Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness

Critical Care

Helena Levin¹  Martin Annborn²  Martin Spångfors³  Maria Lengquist⁴  Oscar H. M. Lundberg⁴  Attila Frigyesi⁴  Hans Friberg⁴  Olle Melander⁵  Janin Schulte⁶  Deborah Bergmann⁶ 

[1] Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, 22185, Lund, Sweden;Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, 22185, Lund, Sweden;Department of Anaesthesia and Intensive Care, Helsingborg Hospital, 25437, Helsingborg, Sweden;Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, 22185, Lund, Sweden;Department of Anaesthesia and Intensive Care, Kristianstad Hospital, 29133, Kristianstad, Sweden;Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, 22185, Lund, Sweden;Department of Intensive and Perioperative Care, Skåne University Hospital, 20502, Malmö, Sweden;Department of Infectious diseases, Skåne University Hospital, 20502, Malmö, Sweden;Department of Internal medicine, Skåne University Hospital, 20502, Malmö, Sweden;SphingoTec GmbH, 16761, Henningsdorf, Germany;

关键词: Critical illness;    Sepsis;    Septic shock;    Adrenomedullin;    Bioactive adrenomedullin;    Biomarkers;    Cut-off;   

DOI  :  10.1186/s13054-020-03351-1

来源: Springer

【 摘 要 】

BackgroundBiomarkers can be of help to understand critical illness and to identify and stratify sepsis. Adrenomedullin is a vasoactive hormone, with reported prognostic and potentially therapeutic value in sepsis. The primary aim of this study was to investigate the association of circulating bioactive adrenomedullin (bio-ADM) levels at intensive care unit (ICU) admission with mortality in sepsis patients and in a general ICU population. Secondary aims included the association of bio-ADM with organ failure and the ability of bio-ADM to identify sepsis.MethodsIn this retrospective observational study, adult patients admitted to one of four ICUs during 2016 had admission bio-ADM levels analysed. Age-adjusted odds ratios (OR) with 95% CI for log-2 transformed bio-ADM, and Youden’s index derived cut-offs were calculated. The primary outcome was 30-day mortality, and secondary outcomes included the need for organ support and the ability to identify sepsis.ResultsBio-ADM in 1867 consecutive patients were analysed; 632 patients fulfilled the sepsis-3 criteria of whom 267 had septic shock. The median bio-ADM in the entire ICU population was 40 pg/mL, 74 pg/mL in sepsis patients, 107 pg/mL in septic shock and 29 pg/mL in non-septic patients. The association of elevated bio-ADM and mortality in sepsis patients and the ICU population resulted in ORs of 1.23 (95% CI 1.07–1.41) and 1.22 (95% CI 1.12–1.32), respectively. The association with mortality remained after additional adjustment for lactate in sepsis patients. Elevated bio-ADM was associated with an increased need for dialysis with ORs of 2.28 (95% CI 2.01–2.59) and 1.97 (95% CI 1.64–2.36) for the ICU population and sepsis patients, respectively, and with increased need of vasopressors, OR 1.33 (95% CI 1.23–1.42) (95% CI 1.17–1.50) for both populations. Sepsis was identified with an OR of 1.78 (95% CI 1.64–1.94) for bio-ADM, after additional adjustment for severity of disease. A bio-ADM cut-off of 70 pg/mL differentiated between survivors and non-survivors in sepsis, but a Youden’s index derived threshold of 108 pg/mL performed better.ConclusionsAdmission bio-ADM is associated with 30-day mortality and organ failure in sepsis patients as well as in a general ICU population. Bio-ADM may be a morbidity-independent sepsis biomarker.

【 授权许可】

CC BY